Enter a Ticker Symbol To Get Your Free Bull/Bear Rating & Ranking Report from "Stock Scientist" Mike Turner

Dividend Quote

CELGZ

Celgene Corp

Add to Scorecard

New Report from the Award-winning Analyst Who Beat the Market Over 15 Years

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.

CELGZ:Celgene Corp - Stock Quote and Dividend Data

LATEST CLOSE PRICE

$0.77

EXCHANGE

NASDAQ

SECTOR

Health Care

CELGZ
Celgene Corp Dividend Information
Trailing 12 Month Dividend Yield898.37%
Projected 10 Year Dividend Yield898.37%
Dividend Yield 5 Year Average0.00%
Dividend Rate$6.93
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years

Dividend Payment TypeNone
Dividend Declaration DateNone
Dividend Ex DateOct. 08, 2013
Dividend Record DateOct. 04, 2013
Dividend Pay DateOct. 07, 2013
Dividend Amount Current$6.933
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend Paid2013

FREE INVESTOR BRIEFING

Collect an 8% Yield on this "Government Mandated Income Opportunity"

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.
CELGZ
Celgene Corp Stock Information
Latest Close Price$0.77
52-Week Low/High$0.11 - $2.65
Percent Held by Institutions3.84%
Revenue$18,619,000,000
Net Income$3,974,000,000
Cash Flow$1,924,000,000
EPS1.54%
Market Cap$0
PE Ratio0
PE Ratio to Industry65%
Debt-Equity Ratio417.00%
Debt-Equity to Industry1.39%
Total Return Last 12 Months-3.77%
Total Return Last 3 Years-22.86%
Total Return Last 5 Years-74.46%
Latest Trade DateDec. 13, 2018
CELGZ
Celgene Corp Dividend Payment History
CELGZ
Celgene Corp Other Details

Celgene is a biopharmaceutical company engaged primarily in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases through solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. Co.'s primary commercial stage products include REVLIMID®, POMALYST®/IMNOVID®, OTEZLA®, ABRAXANE®, VIDAZA®, azacitidine for injection (generic version of VIDAZA®), THALOMID® (sold as THALOMID® or Thalidomide Celgene® outside of the U.S.) and and IDHIFA®. In addition, Co. provides other product sales and licensing arrangements.

Web Sitewww.celgene.com
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Try Dividend Investor PREMIUM for as low as $29

  • Dividend Allstars™ Tool
  • Proprietary Ex-dividend Calendar
  • Dividend Scorecard™ Portfolio Tracker
  • Customized Dividend Stock Screener
  • 4 FREE special reports from leading dividend experts
  • And much more...
 
Celgene Corp Dividend Stock News and Updates

Dec. 08, 2018CLOSE PRICE INCREASE: Celgene Corp (NASDAQ: CELGZ) on 12-08-2018 increased close price > 10% from $0.70 to $0.80

Read more...

Dec. 07, 2018CLOSE PRICE DECREASE: Celgene Corp (NASDAQ: CELGZ) on 12-07-2018 decreased close price > 10% from $0.91 to $0.70

Read more...

Dec. 05, 2018CLOSE PRICE INCREASE: Celgene Corp (NASDAQ: CELGZ) on 12-05-2018 increased close price > 10% from $0.81 to $0.91

Read more...
More Celgene Corp Dividend News
Biotechnology Dividend Stock News and Updates

Dec. 14, 2018CLOSE PRICE INCREASE: Affymax Inc (OTCBB: AFFY) on 12-14-2018 increased close price > 10% from $0.01 to $0.02

Read more...

Dec. 14, 2018CLOSE PRICE INCREASE: Anthera Pharmaceuticals Inc (OTCBB: ANTH) on 12-14-2018 increased close price > 10% from $0.04 to $0.04

Read more...

Dec. 14, 2018CLOSE PRICE DECREASE: CTD Holdings Inc (FL) (OTCBB: CTDH) on 12-14-2018 decreased close price > 10% from $0.95 to $0.83

Read more...
More Biotechnology Dividend News
FREE REPORT
X
Bryan Perry Dividend Income Expert Bryan Perry

Earn 8% on this "Government Mandated Income Opportunity"

X

Search Dividend Investor